Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PWP1 Affects Gastric Cancer Progression by Regulating p53 and JAK1 and Its Expression in Gastric Cancer.

NCT06392750 is registered in ClinicalTrials.gov with Northern Jiangsu People's Hospital as lead sponsor.

NCT NCT06392750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06392750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PWP1 Affects Gastric Cancer Progression by Regulating p53 and JAK1 and Its Expression in Gastric Cancer.
Lead sponsor
Northern Jiangsu People's Hospital
Phase
Observational
Overall status
Completed
Start date
May 1, 2021
Completion date
April 1, 2024
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnosis, gastric cancer